Domestic Innovation in Cancer Diagnosis: Argenit

Domestic Innovation in Cancer Diagnosis: Argenit Argenit simplifies disease diagnosis and treatment processes using digital imaging systems and contributes to the healthcare sector with its domestically developed artificial intelligence systems. The company designs imaging systems needed by genetics and pathology departments and produces effective solutions especially for early detection of cancer. Healthcare informatics company Argenit provides artificial intelligence-driven solutions that enable early diagnosis for patients and determine appropriate treatment, thereby increasing treatment success rates. As the only company in its field developing software with Turkish language support, Argenit digitalizes laboratory data. The chromosome analysis system developed by Argenit achieves 99.9 percent success in accurately diagnosing many genetic diseases ranging from Down syndrome to cancer. The high-tech chromosome analysis system that can only be produced by four countries in the world is regarded as the "gold standard" in diagnosing genetic diseases. Chromosome analysis represents a market in Turkey with approximately half a million tests annually and a transaction volume of 30 million dollars. Digital pathology, another cutting-edge technology used in cancer diagnosis, is expected to grow approximately twofold from its 2017 market size of 389.9 million dollars to 992.1 million dollars in 2025, according to the 2025 Digital Pathology Market Report. Argenit, a domestic player in these two markets with a combined size approaching one billion dollars, produces diagnostic systems using its artificial intelligence technology. Emphasizing that the chromosome analysis system adds a new dimension to digitalization in healthcare, Burak Buyrukbilen, co-founder of Argenit, made the following statement on the matter: "Artificial intelligence algorithms can recognize cancer cells just like facial recognition systems do. Our digital image analysis system, which reduces error margins in diagnosis, stands out as a technology that increases success percentages in treatment processes. Among our objectives is to reduce dependence on imports with our domestic and national products offered to the healthcare sector. Our domestic solutions and the use of our own resources in healthcare make Argenit distinctive through accessibility, cost-effectiveness, Turkish language support, and round-the-clock technical support," he said.